Molecular Approaches in Fetal Malformations, Dynamic Anomalies and Soft Markers: Diagnostic Rates and Challenges-Systematic Review of the Literature and Meta-Analysis

Overview

Journal Diagnostics (Basel)

Specialty Radiology

Date 2022 Mar 25

PMID 35328129

Authors

Gioia Mastromoro

Daniele Guadagnolo

Nader Khaleghi Hashemian

Enrica Marchionni

Alice Traversa

Antonio Pizzuti

Affiliations

Soon will be listed here.

Abstract

Fetal malformations occur in 2-3% of pregnancies. They require invasive procedures for cytogenetics and molecular testing. "Structural anomalies" include non-transient anatomic alterations. "Soft markers" are often transient minor ultrasound findings. Anomalies not fitting these definitions are categorized as "dynamic". This meta-analysis aims to evaluate the diagnostic yield and the rates of variants of uncertain significance (VUSs) in fetuses undergoing molecular testing (chromosomal microarray (CMA), exome sequencing (ES), genome sequencing (WGS)) due to ultrasound findings. The CMA diagnostic yield was 2.15% in single soft markers (vs. 0.79% baseline risk), 3.44% in multiple soft markers, 3.66% in single structural anomalies and 8.57% in multiple structural anomalies. Rates for specific subcategories vary significantly. ES showed a diagnostic rate of 19.47%, reaching 27.47% in multiple structural anomalies. WGS data did not allow meta-analysis. In fetal structural anomalies, CMA is a first-tier test, but should be integrated with karyotype and parental segregations. In this class of fetuses, ES presents a very high incremental yield, with a significant VUSs burden, so we encourage its use in selected cases. Soft markers present heterogeneous CMA results from each other, some of them with risks comparable to structural anomalies, and would benefit from molecular analysis. The diagnostic rate of multiple soft markers poses a solid indication to CMA.

Citing Articles

Fetal Hydrops: Genetic Dissection of an Unspecific Sonographic Finding-A Comprehensive Review.

Mastromoro G, Guadagnolo D, De Luca A, Rongioletti M, Pizzuti A Diagnostics (Basel). 2025; 15(4).

PMID: 40002616 PMC: 11854127. DOI: 10.3390/diagnostics15040465.

Identification of novel biallelic mutations in CFAP53 associated with fetal situs inversus totalis and literature review.

Guo Z, Tan M, Zhu H, Lou G, Xia X, Yang W J Appl Genet. 2025; .

PMID: 39969775 DOI: 10.1007/s13353-025-00950-y.

Chromosomal Abnormalities Detected by Chromosomal Microarray Analysis and Karyotype in Fetuses with Ultrasound Abnormalities.

Lan L, Luo D, Lian J, She L, Zhang B, Zhong H Int J Gen Med. 2024; 17:4645-4658.

PMID: 39429961 PMC: 11488349. DOI: 10.2147/IJGM.S483290.

Diagnostic and prognostic role of soft ultrasound markers in prenatal detection and assessment of foetal abnormalities.

Moradi B, Bahrami A, Vafaei S, Sharifpour S, Shariatinia F, Rezvanimehr A Prz Menopauzalny. 2024; 23(2):94-108.

PMID: 39391522 PMC: 11462147. DOI: 10.5114/pm.2024.141092.

Application of Whole-Exome Sequencing in the Prenatal Diagnosis of Foetuses With Central Nervous System Abnormalities.

Luo C, Wen E, Liu Y, Wang H, Jia B, Chen L Mol Genet Genomic Med. 2024; 12(10):e70016.

PMID: 39359128 PMC: 11447275. DOI: 10.1002/mgg3.70016.

References

Wang J, Zhang Z, Li Q, Zhu H, Lai Y, Luo W . Prenatal diagnosis of chromosomal aberrations by chromosomal microarray analysis in foetuses with ventriculomegaly. Sci Rep. 2020; 10(1):20765. PMC: 7699619. DOI: 10.1038/s41598-020-77400-8. View

Muys J, Blaumeiser B, Janssens K, Loobuyck P, Jacquemyn Y . Chromosomal microarray analysis in prenatal diagnosis: ethical considerations of the Belgian approach. J Med Ethics. 2019; 46(2):104-109. DOI: 10.1136/medethics-2018-105186. View

Svirsky R, Reches A, Brabbing-Goldstein D, Bar-Shira A, Yaron Y . Association of aberrant right subclavian artery with abnormal karyotype and microarray results. Prenat Diagn. 2017; 37(8):808-811. DOI: 10.1002/pd.5092. View

Lefebvre M, Bruel A, Tisserant E, Bourgon N, Duffourd Y, Collardeau-Frachon S . Genotype-first in a cohort of 95 fetuses with multiple congenital abnormalities: when exome sequencing reveals unexpected fetal phenotype-genotype correlations. J Med Genet. 2020; 58(6):400-413. DOI: 10.1136/jmedgenet-2020-106867. View

Chang Q, Yang Y, Peng Y, Liu S, Li L, Deng X . Prenatal detection of chromosomal abnormalities and copy number variants in fetuses with ventriculomegaly. Eur J Paediatr Neurol. 2020; 25:106-112. DOI: 10.1016/j.ejpn.2020.01.016. View

Westerfield L, Stover S, Mathur V, Nassef S, Carter T, Yang Y . Reproductive genetic counseling challenges associated with diagnostic exome sequencing in a large academic private reproductive genetic counseling practice. Prenat Diagn. 2015; 35(10):1022-9. DOI: 10.1002/pd.4674. View

Li S, Han X, Ye M, Chen S, Shen Y, Niu J . Should chromosomal microarray be offered to fetuses with ultrasonographic soft markers in second trimester: A prospective cohort study and meta-analysis. Prenat Diagn. 2020; 40(12):1569-1577. DOI: 10.1002/pd.5815. View

An G, Lin Y, Xu L, Huang H, Liu S, Yu Y . Application of chromosomal microarray to investigate genetic causes of isolated fetal growth restriction. Mol Cytogenet. 2018; 11:33. PMC: 5987400. DOI: 10.1186/s13039-018-0382-4. View

Li S, Han X, Wang Y, Chen S, Niu J, Qian Z . Chromosomal microarray analysis in fetuses with congenital anomalies of the kidney and urinary tract: A prospective cohort study and meta-analysis. Prenat Diagn. 2019; 39(3):165-174. DOI: 10.1002/pd.5420. View

10.

Zhou J, Yang Z, Sun J, Liu L, Zhou X, Liu F . Whole Genome Sequencing in the Evaluation of Fetal Structural Anomalies: A Parallel Test with Chromosomal Microarray Plus Whole Exome Sequencing. Genes (Basel). 2021; 12(3). PMC: 7999180. DOI: 10.3390/genes12030376. View

11.

Mackie F, Carss K, Hillman S, Hurles M, Kilby M . Exome Sequencing in Fetuses with Structural Malformations. J Clin Med. 2015; 3(3):747-62. PMC: 4449643. DOI: 10.3390/jcm3030747. View

12.

Mellis R, Chandler N, Chitty L . Next-generation sequencing and the impact on prenatal diagnosis. Expert Rev Mol Diagn. 2018; 18(8):689-699. DOI: 10.1080/14737159.2018.1493924. View

13.

Liao C, Fu F, Li R, Xie G, Zhang Y, Li J . Implementation of high-resolution SNP arrays in the investigation of fetuses with ultrasound malformations: 5 years of clinical experience. Clin Genet. 2013; 86(3):264-9. DOI: 10.1111/cge.12271. View

14.

Lerman-Sagie T, Pogledic I, Leibovitz Z, Malinger G . A practical approach to prenatal diagnosis of malformations of cortical development. Eur J Paediatr Neurol. 2021; 34:50-61. DOI: 10.1016/j.ejpn.2021.08.001. View

15.

Fantasia I, Stampalija T, Sirchia F, Della Pieta I, Ottaviani Giammarco C, Guidolin F . First-trimester absent nasal bone: is it a predictive factor for pathogenic CNVs in the low-risk population?. Prenat Diagn. 2020; 40(12):1563-1568. DOI: 10.1002/pd.5812. View

16.

Zhang X, Ren Y, Song R, Wang L, Xu H, Xie X . Combined exome sequencing and deep phenotyping in highly selected fetuses with skeletal dysplasia during the first and second trimesters improves diagnostic yield. Prenat Diagn. 2021; 41(11):1401-1413. DOI: 10.1002/pd.5974. View

17.

Xia Y, Yang Y, Huang S, Wu Y, Li P, Zhuang J . Clinical application of chromosomal microarray analysis for the prenatal diagnosis of chromosomal abnormalities and copy number variations in fetuses with congenital heart disease. Prenat Diagn. 2018; 38(6):406-413. DOI: 10.1002/pd.5249. View

18.

Callaway J, Shaffer L, Chitty L, Rosenfeld J, Crolla J . The clinical utility of microarray technologies applied to prenatal cytogenetics in the presence of a normal conventional karyotype: a review of the literature. Prenat Diagn. 2013; 33(12):1119-23. PMC: 4285999. DOI: 10.1002/pd.4209. View

19.

Nyberg D, Souter V, Young S, Luthhardt F, Luthy D . Isolated sonographic markers for detection of fetal Down syndrome in the second trimester of pregnancy. J Ultrasound Med. 2001; 20(10):1053-63. DOI: 10.7863/jum.2001.20.10.1053. View

20.

Monaghan K, Leach N, Pekarek D, Prasad P, Rose N . The use of fetal exome sequencing in prenatal diagnosis: a points to consider document of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2020; 22(4):675-680. DOI: 10.1038/s41436-019-0731-7. View